494 related articles for article (PubMed ID: 16541475)
21. [Therapeutic strategies in idiopatic inflammatory myopathies].
Chakour R; Leimgruber A; Bart PA; Spertini F
Rev Med Suisse; 2009 Apr; 5(199):812-8. PubMed ID: 19441746
[TBL] [Abstract][Full Text] [Related]
22. [Clinical and pathological investigation of polymyositis and dermatomyositis: report of 83 cases].
Li Q; Lu BX; Zhou L; An SL
Di Yi Jun Yi Da Xue Xue Bao; 2002 Dec; 22(12):1139-40. PubMed ID: 12480599
[TBL] [Abstract][Full Text] [Related]
23. Treatment of polymyositis and dermatomyositis.
Kaye SA; Isenberg DA
Br J Hosp Med; 1994 Nov 2-15; 52(9):463-8. PubMed ID: 7874361
[TBL] [Abstract][Full Text] [Related]
24. Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients.
Marie I; Menard JF; Hatron PY; Hachulla E; Mouthon L; Tiev K; Ducrotte P; Cherin P
Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1748-55. PubMed ID: 20722047
[TBL] [Abstract][Full Text] [Related]
25. Therapy of polymyositis and dermatomyositis.
Marie I
Presse Med; 2011 Apr; 40(4 Pt 2):e257-70. PubMed ID: 21334847
[TBL] [Abstract][Full Text] [Related]
26. Resistive exercise in the rehabilitation of polymyositis/dermatomyositis.
Escalante A; Miller L; Beardmore TD
J Rheumatol; 1993 Aug; 20(8):1340-4. PubMed ID: 8230016
[TBL] [Abstract][Full Text] [Related]
27. [The practice guideline 'Dermatomyositis, polymyositis and sporadic inclusion body myositis'].
Hoogendijk JE; Bijlsma JW; van Engelen BG; Lindeman E; van Royen-Kerkhof A; de Rie MA; de Visser M; Jennekens FG;
Ned Tijdschr Geneeskd; 2005 Sep; 149(38):2104-11. PubMed ID: 16201600
[TBL] [Abstract][Full Text] [Related]
28. Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine.
Nawata Y; Kurasawa K; Takabayashi K; Miike S; Watanabe N; Hiraguri M; Kita Y; Kawai M; Saito Y; Iwamoto I
J Rheumatol; 1999 Jul; 26(7):1527-33. PubMed ID: 10405940
[TBL] [Abstract][Full Text] [Related]
29. [Immunoglobulins or plasma exchange? New treatment methods in polymyositis and dermatomyositis: plasma exchange and intravenous immunoglobulins].
Chérin P; Herson S
Ann Med Interne (Paris); 1993; 144(8):521-5. PubMed ID: 8179241
[TBL] [Abstract][Full Text] [Related]
30. Effects of immunosuppressive treatment on interleukin-15 and interleukin-15 receptor α expression in muscle tissue of patients with polymyositis or dermatomyositis.
Zong M; Loell I; Lindroos E; Nader GA; Alexanderson H; Hallengren CS; Borg K; Arnardottir S; McInnes IB; Lundberg IE
Ann Rheum Dis; 2012 Jun; 71(6):1055-63. PubMed ID: 22267334
[TBL] [Abstract][Full Text] [Related]
31. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.
Stasi R; Stipa E; Del Poeta G; Amadori S; Newland AC; Provan D
Rheumatology (Oxford); 2006 Nov; 45(11):1432-6. PubMed ID: 16632482
[TBL] [Abstract][Full Text] [Related]
32. Rituximab for the treatment of the skin manifestations of dermatomyositis: a report of 3 cases.
Dinh HV; McCormack C; Hall S; Prince HM
J Am Acad Dermatol; 2007 Jan; 56(1):148-53. PubMed ID: 17097377
[TBL] [Abstract][Full Text] [Related]
33. Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine.
Schiopu E; Phillips K; MacDonald PM; Crofford LJ; Somers EC
Arthritis Res Ther; 2012 Jan; 14(1):R22. PubMed ID: 22284862
[TBL] [Abstract][Full Text] [Related]
34. Polymyositis/dermatomyositis and interstitial lung disease: a new therapeutic approach with T-cell-specific immunosuppressants.
Takada K; Nagasaka K; Miyasaka N
Autoimmunity; 2005 Aug; 38(5):383-92. PubMed ID: 16227154
[TBL] [Abstract][Full Text] [Related]
35. [Coexistence of hypothyroidism with polymyositis or dermatomyositis].
Lukjanowicz M; Bobrowska-Snarska D; Brzosko M
Ann Acad Med Stetin; 2006; 52 Suppl 2():49-55. PubMed ID: 17471837
[TBL] [Abstract][Full Text] [Related]
36. [Immunosuppressant treatment in refractory myositis. Our experience].
Danieli MG; Spalletta C; Moretti R; Calabrese V; Marchetti A; Gabrielli A; Logullo F
Recenti Prog Med; 2009 Oct; 100(10):451-7. PubMed ID: 20030167
[TBL] [Abstract][Full Text] [Related]
37. Rituximab pharmacokinetics in patients with rheumatoid arthritis: B-cell levels do not correlate with clinical response.
Breedveld F; Agarwal S; Yin M; Ren S; Li NF; Shaw TM; Davies BE
J Clin Pharmacol; 2007 Sep; 47(9):1119-28. PubMed ID: 17766699
[TBL] [Abstract][Full Text] [Related]
38. Methotrexate and azathioprine treatment of childhood dermatomyositis.
Jacobs JC
Pediatrics; 1977 Feb; 59(2):212-8. PubMed ID: 299938
[TBL] [Abstract][Full Text] [Related]
39. Rituximab in the treatment of refractory dermatomyositis.
Chiappetta N; Steier J; Gruber B
J Clin Rheumatol; 2005 Oct; 11(5):264-6. PubMed ID: 16357773
[TBL] [Abstract][Full Text] [Related]
40. Clinical and serologic features of patients with polymyositis or dermatomyositis.
Holden DJ; Brownell AK; Fritzler MJ
Can Med Assoc J; 1985 Mar; 132(6):649-53. PubMed ID: 3872156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
